SEER Q3 2021 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$98M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$479,00022.3% margin

Operating Income

-$18M-859.7% margin

Net Income

-$18M-857.1% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+60.8%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$528M

Total Liabilities

$13M

Stockholders' Equity

$515M

Cash & Equivalents

$331M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$479,000	$0	—
Operating Income	-$18M	-$8M	-119.1%
Net Income	-$18M	-$8M	-123.4%

Revenue Segments

Product

$858,00040%

Related Party

$787,00037%

Service

$500,00023%

Grant

$10,0000%